In Brief This Week: Thermo Fisher Scientific; Corning; Life Technologies; Affymetrix; Saladax; Epistem; MLSC | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific this week said that its board of directors has declared a quarterly cash dividend of $.13 per share. It's payable on Oct. 15, to shareholders of record as of Sept. 17.


Corning has opened a new life sciences lab in Palo Alto, Calif., in its existing Corning West Technology Center. The lab will provide customers and researchers with onsite expertise in using the firm's technologies for cell-based, biochemical, and molecular biology assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.